Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Norovirus VP1 P domain (GI.1) is the surface-exposed region of the major capsid protein VP1 of the Genogroup I, Genotype 1 norovirus, which is the prototypical Norwalk virus (Prasad et al., 1999, Science). This domain plays a pivotal role in viral infection by mediating attachment to host cells through interactions with Histo-Blood Group Antigens (HBGAs) (Tan & Jiang, 2005, J Virol). Structurally, the P domain is composed of P1 and P2 subdomains, where the P2 subdomain forms the most distal part of the viral capsid and contains the HBGA-binding interface (Donaldson et al., 2010, Immunol Rev). As the primary target for neutralizing antibodies, the P domain is the central component in the development of norovirus vaccines, such as Virus-Like Particles (VLPs) and P-particle candidates (Atmar et al., 2011, NEJM). Therapeutic strategies targeting this domain focus on small-molecule HBGA mimetics that competitively inhibit viral binding or monoclonal antibodies that block entry. Understanding the structural variability of the P domain is essential for addressing the challenges of strain diversity and antigenic drift in norovirus outbreaks.
Inhibition of viral attachment to host histo-blood group antigens (HBGAs) and neutralization of viral entry through competitive binding or steric hindrance.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norovirus major capsid protein VP1 protruding domain (GI.1) (VP1 P domain (GI.1)).